ObGyn Intelligence

ObGyn Intelligence

ObGyn Intelligence+

Misoprostol for Cervical Ripening: Informed Consent Is Not Optional

The Responsibility Clause - Should patients be informed that a recommended medication is not FDA approved?

Amos Grünebaum, MD's avatar
Amos Grünebaum, MD
Jun 30, 2025
∙ Paid

The Guideline and the Gap

In July 2025, ACOG released Clinical Practice Guideline No. 9, recommending the use of misoprostol for cervical ripening and labor induction. Misoprostol (aka ‘Cytotec’) is a medication approved for preventjng and treating stomach ulcers and it is inexpensive, and widely used. In pregnancy, doctors can give it orally of vaginal…

User's avatar

Continue reading this post for free, courtesy of Amos Grünebaum, MD.

Or purchase a paid subscription.
© 2026 Amos Grünebaum, MD · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture